The results of a new trial show that a common herpes medication can reduce levels of HIV independent of herpes infection.

The trial was carried out by an international group of researchers – including a team from Case Western Reserve University (CWRU) in Cleveland, OH – and is reported in the journal Clinical Infectious Diseases.

The investigators found – contrary to previous studies – that the commonly used herpes drug valacyclovir (known under the brand name Valtrex) reduced levels of HIV-1 even in patients that did not have herpes.

Continue Reading

READ FULL ARTICLE Curated publisher From Medical News Today